Deep Value: cash covers more than 100% of the stock price

This company holds roughly $812 in cash and investments — more than its entire stock-market value, based on its latest quarterly filing. You're paying very little for the actual business. Sometimes that's a genuine bargain or a takeover target, sometimes it's cheap for a reason. Not a buy signal on its own — always ask why it's this cheap.

Verde Science

VRCI

Biotechnology · Healthcare

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Winston Score History

The full picture

Verde Science, Inc. is a small biotechnology company focused on developing medical treatments. Biotechnology companies like this one work on creating new drugs or therapies, typically targeting specific diseases or medical conditions. At its current stage, Verde Science appears to be a pre-revenue or early-stage company, meaning it has not yet brought a commercial product to market.

The company generates little to no revenue, which is common for early-stage biotech firms that are still in research or clinical development. Its zero gross and operating margins confirm it is spending money on development without meaningful sales coming in yet. The unusually high ROIC figure likely reflects accounting quirks rather than true business performance at this stage. The primary risk for Verde Science is the same as most small biotechs: it must successfully advance its pipeline through costly clinical trials, secure regulatory approval, and raise enough capital to survive before generating any real revenue.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

+69.1% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

13.2%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~0 months

$812 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

Verde Science has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

—

Data not available

Profit after running costs

Operating Margin

N/A

—

Data not available

Return on the money invested

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

Data not available

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

—

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial